Harmony Labs, Inc. has completed construction and validation of its new 135,000-sq.-ft., state-of-the-art R&D and manufacturing facility. The new facility will house the company's research and analytical chemist team, as well as serve as the central location for the manufacturing of pharmaceutical, OTC, and cosmetic liquids and semi-solids.
“This is a significant milestone in our history and one that signifies Harmony Labs’ continued commitment to being the leading expert in skin care development and manufacturing,” said Will Lynch, chief executive officer and president of Harmony Labs.
With this new facility, the company now occupies more than 200,000 sq. ft. of operations. Services include on-site formulation, development, analytical work including micro testing, and ICH stability, and validation programs for OTC and Rx products.